Parallel Advisors, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,385
-16.3%
6760.0%0.00%0.0%
Q3 2022$16,000
+33.3%
6760.0%0.00%0.0%
Q2 2022$12,000
-20.0%
6760.0%0.00%0.0%
Q1 2022$15,000
-40.0%
6760.0%0.00%0.0%
Q4 2021$25,000
+19.0%
6760.0%0.00%0.0%
Q3 2021$21,0000.0%6760.0%0.00%0.0%
Q2 2021$21,000
+40.0%
6760.0%0.00%0.0%
Q1 2021$15,000
+15.4%
6760.0%0.00%0.0%
Q4 2020$13,000
-91.8%
676
-86.2%
0.00%
-90.0%
Q3 2020$158,000
+22.5%
4,909
+9.8%
0.01%
+25.0%
Q2 2020$129,0004,4700.01%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$49,189,39517.79%
Euclidean Capital LLC 432,900$7,943,7156.97%
GREAT POINT PARTNERS LLC 1,355,151$24,867,0214.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 875,984$16,074,3063.02%
Trustees of Columbia University in the City of New York 80,580$1,478,6432.64%
Perceptive Advisors 2,291,608$42,051,0071.24%
Cormorant Asset Management, LP 650,000$11,9280.79%
Alphabet Inc. 540,270$9,913,9550.55%
Redmile Group, LLC 688,132$12,627,2220.55%
Orbimed Advisors 1,251,070$22,957,1350.45%
View complete list of RAPT THERAPEUTICS INC shareholders